|
MechanismVoltage-gated sodium channels blockers |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Owen-Barry Pharmaceuticals, Inc.
0 Patents (Medical) associated with Owen-Barry Pharmaceuticals, Inc.
100 Deals associated with Owen-Barry Pharmaceuticals, Inc.
100 Translational Medicine associated with Owen-Barry Pharmaceuticals, Inc.